Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
Boehringer Ingelheim
Boehringer Ingelheim
Eli Lilly and Company
Children's Oncology Group
Sheffield Teaching Hospitals NHS Foundation Trust
Xian-Janssen Pharmaceutical Ltd.
Alliance for Clinical Trials in Oncology
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC